Literature DB >> 747695

Pharmacokinetics of thiopentone: effects of enflurane and nitrous oxide anaesthesia and surgery.

M M Ghoneim, M J Van Hamme.   

Abstract

Plasma concentrations of thiopentone following the injection of 3.5 mg kg-1 i.v. were studied in six patients who received enflurane and nitrous oxide anaesthesia and six volunteers. We identified a three-compartment open model system containing both a "shallow" and a "deep" peripheral compartment in all the patients and half of the controls, and a two-compartment open model for the remaining volunteers. The distribution of thiopentone to the tissues was very rapid, the alpha and beta distribution half-lives averaging 2.5 min and 46.4 min respectively for the patient group and 2.8 min and 48.7 min for the control group. The wide distribution of the drug was indicated by the apparent volume of distribution, the means of which varied between 2 and 1.5 times body weight. The mean elimination half-life was 5.1 h for the patients and 5.7 h for the volunteers. The return of the drug to the central compartment from the deep peripheral compartment was the rate-controlling factor in its elimination. Neither enflurane and nitrous oxide anaesthesia nor the stress of surgery affected the distribution or clearance of the drug from plasma.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 747695     DOI: 10.1093/bja/50.12.1237

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  11 in total

Review 1.  Intravenous anaesthetic agents. Pharmacokinetic-pharmacodynamic relationships.

Authors:  B N Swerdlow; F O Holley
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

Review 2.  Pharmacokinetics in intravenous anaesthetic practice.

Authors:  P Duvaldestin
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

Review 3.  Pharmacokinetics in anaesthesia.

Authors:  J A Moffat; B Milne
Journal:  Can Anaesth Soc J       Date:  1983-05

4.  Elimination kinetics of thiopentone in mothers and their newborn infants.

Authors:  F Gaspari; G Marraro; G F Penna; R Valsecchi; M Bonati
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Effect or premedicants, intravenous anaesthetic agents an local anaesthetics on phagocytosis in vitro.

Authors:  G C Moudgil
Journal:  Can Anaesth Soc J       Date:  1981-11

6.  Development of a model for integrated pharmacokinetic and pharmacodynamic studies of intravenous anaesthetic agents: applications to minaxolone.

Authors:  L E Mather; L T Seow; J G Roberts; G K Gourlay; M J Cousins
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 7.  Pharmacodynamics and pharmacokinetics of thiopental.

Authors:  H Russo; F Bressolle
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

8.  Thiopental bolus during carotid endarterectomy-rational drug therapy?

Authors:  J A Moffat; M J McDougall; D Brunet; F Saunders; E S Shelley; F W Cervenko; B Milne
Journal:  Can Anaesth Soc J       Date:  1983-11

9.  Variability of thiopental clearance in routine critical care patients.

Authors:  H Russo; J Brés; M P Duboin; B Roquefeuil
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

10.  An integrated study of pharmacokinetics and pharmacodynamics of chlormethiazole in healthy young volunteers.

Authors:  L T Seow; L E Mather; J G Roberts
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.